Kennedy, N., Lin, S., Goodhand, J., Chanchlani, N., Hamilton, B., Bewshea, C., Nice, R., Chee, D., Cummings, J., Fraser, A., Irving, P., Kamperidis, N., Kok, K., Lamb, Christopher A., MacDonald, J., Mehta, S., Pollok, R., Raine, T., Smith, P., Verma, A., Jochum, S., McDonald, T., Sebastian, S., Lees, C., Powell, N. & Ahmad, T. 2021, 'Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD', Gut, 70(10), pp. 1884-1893. http://dx.doi.org/10.1136/gutjnl-2021-324789